Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Psychiatry/Neuroscience

CME

The Weathering Hypothesis of Aging: Part II

This month, Bruce S. McEwen, Ph.D. discusses
CME credit is no longer available for this conference.

Course Authors

Bruce S. McEwen, Ph.D.

Dr. McEwen reports no commercial conflict of interest.

Estimated course time: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Describe how the HPA axis is controlled by a number of extra-hypothalamic brain structures which have inputs to the hypothalamus

  • Outline how individual differences in HPA activity arise in animal models from early-life experiences

  • Discuss individual differences in "weathering", i.e., rate of aging of the human brain and show how they may parallel animal models.

 

TERMS AND CONDITIONS

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity

Courses You Might Like

Emerging Research on the Use of Psychedelics in the Treatment of Mental Illness

In the last 30 years, revived interest in the application of psychedelic compounds in psychiatry has created a huge body of scientific knowledge on the pharmacological and therapeutic action of these compounds. these compounds.
Authors: Danilo De Gregorio, PharmD, Ph.D.
Estimated Time: 1 Hour
View Course
More

The Impact of COVID-19 on Mental Health

COVID-19 and the pandemic greatly affected mental health.
Authors: Roger Ho M.D., F.R.C.Psych., F.R.C.P.C., and Cyrus Ho M.B.B.S., M.R.C.Psych.
Estimated Time: 1 Hour
View Course
More

Molecular Mechanisms of Cognitive Deficits in Schizophrenia

Treatment of the cognitive symptoms of schizophrenia has been the focus of much research because they are highly predictive of long-term functional outcome.
Authors: Sarah Canetta, Ph.D., and Christoph Kellendonk, Ph.D.
Estimated Time: 1 Hour
View Course
More

PTSD: Current Therapies

Psychological trauma, defined as threat to life or integrity of yourself or someone close to you, affects over half of the U.S. population at some time in their lives.
Authors: J. Douglas Bremner, M.D.
Estimated Time: 1 Hour
View Course
More

Current and Emerging Therapies for Relapsing-Remitting Multiple Sclerosis

No other area of neurology has seen such a remarkable explosion of new drugs.
Authors: Aaron Miller, M.D..
Estimated Time: 1 Hour
View Course
More

Glial Cells

Glia are involved in nearly every aspect of brain function, including brain development, homeostasis, information processing, neurological disease and psychiatric illness.
Authors: R. Douglas Fields, Ph.D.
Estimated Time: 1 Hour
View Course
More